Walleye Capital LLC Gamida Cell Ltd. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.53 - $3.39 $148,178 - $328,318	-96,849 Reduced 54.94%	79,420 $126,000
Q2 2022 Aug 08, 2022	BUY	$1.73 - $4.29 $304,945 - $756,194	176,269 New	176,269 $312,000
Q4 2021 Mar 03, 2022	SELL	$2.2 - $4.46 $90,576 - $183,622	-41,171 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.85 - $6.44 $158,508 - $265,141	41,171 New	41,171 $161,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.